US$ 20.43
l carnitine and usada L-Carnitine L-Carnitine Tartrate
Description
The promising activity of the BCL-2 inhibitor Venetoclax in several combinatorial regimens has led to its approval for the treatment of AML patients 11

10.1124/jpet.107.131318

LEATHER Chem

Development of nanoparticles for antimicrobial drug delivery

Plfi, M., Halsz, A
